If you want to try an unapproved drug in the United States, you must be wealthy or lucky. Naomi Lopez Bauman of the Goldwater Institute discusses some promising reforms. We spoke at the State Policy Network Annual Meeting.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.